Evidence map›Paper›PMID 26908574›Full record

ArticlemBio2016

Nanomolar Inhibitors of Trypanosoma brucei RNA Triphosphatase.

Paul Smith, C Kiong Ho, Yuko Takagi, Hakim Djaballah, Stewart Shuman

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Enzymatic Assays to Explore Viral mRNA Capping Machinery.Chembiochem : a European journal of chemical biology · 2021
    Review
  7. Review
  8. Crystal structures of the RNA triphosphatase fromThe Journal of biological chemistry · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Paul SmithMolecular Biology Program, Sloan-Kettering Institute, New York, New York, USA.
C Kiong HoDepartment of Infection Biology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan Department of Biological Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Yuko TakagiDepartment of Biological Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Hakim DjaballahHigh Throughput Screening Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Stewart ShumanMolecular Biology Program, Sloan-Kettering Institute, New York, New York, USA s-shuman@ski.mskcc.org.
Kettering University · USMemorial Sloan Kettering Cancer Center · USUniversity at Buffalo, State University of New York · USUniversity of Tsukuba · JP

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
mRNA Capping EnzymesR01GM052470 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SCHWER, BEATE, SHUMAN, STEWART H · 1995 to 2019
$9.9M
NCI NIH HHS P30 CA008748NCI NIH HHS P30-CA008748NIGMS NIH HHS GM52470NIGMS NIH HHS R01 GM052470
6 · The paper itself

Abstract

unlabelledEukaryal taxa differ with respect to the structure and mechanism of the RNA triphosphatase (RTPase) component of the mRNA capping apparatus. Protozoa, fungi, and certain DNA viruses have a metal-dependent RTPase that belongs to the triphosphate tunnel metalloenzyme (TTM) superfamily. Because the structures, active sites, and chemical mechanisms of the TTM-type RTPases differ from those of mammalian RTPases, the TTM RTPases are potential targets for antiprotozoal, antifungal, and antiviral drug discovery. Here, we employed RNA interference (RNAi) knockdown methods to show that Trypanosoma brucei RTPase Cet1 (TbCet1) is necessary for proliferation of procyclic cells in culture. We then conducted a high-throughput biochemical screen for small-molecule inhibitors of the phosphohydrolase activity of TbCet1. We identified several classes of chemicals-including chlorogenic acids, phenolic glycopyranosides, flavonoids, and other phenolics-that inhibit TbCet1 with nanomolar to low-micromolar 50% inhibitory concentrations (IC50s). We confirmed the activity of these compounds, and tested various analogs thereof, by direct manual assays of TbCet1 phosphohydrolase activity. The most potent nanomolar inhibitors included tetracaffeoylquinic acid, 5-galloylgalloylquinic acid, pentagalloylglucose, rosmarinic acid, and miquelianin. TbCet1 inhibitors were less active (or inactive) against the orthologous TTM-type RTPases of mimivirus, baculovirus, and budding yeast (Saccharomyces cerevisiae). Our results affirm that a TTM RTPase is subject to potent inhibition by small molecules, with the caveat that parallel screens against TTM RTPases from multiple different pathogens may be required to fully probe the chemical space of TTM inhibition. IMPORTANCE: The stark differences between the structure and mechanism of the RNA triphosphatase (RTPase) component of the mRNA capping apparatus in pathogenic protozoa, fungi, and viruses and those of their metazoan hosts highlight RTPase as a target for anti-infective drug discovery. Protozoan, fungal, and DNA virus RTPases belong to the triphosphate tunnel metalloenzyme family. This study shows that a protozoan RTPase, TbCet1 from Trypanosoma brucei, is essential for growth of the parasite in culture and identifies, via in vitro screening of chemical libraries, several classes of potent small-molecule inhibitors of TbCet1 phosphohydrolase activity.

Indexed as

Acid Anhydride HydrolasesAntioxidantsApyraseBinding SitesCaffeic AcidsCatalytic DomainCinnamatesDepsidesDrug DiscoveryEnzyme InhibitorsGallic AcidGlucosidesInhibitory Concentration 50Protozoan ProteinsQuercetinQuinic Acid1,3,4,5-O-tetracaffeoylquinic acid5-galloylgalloylquinic acidAcid Anhydride HydrolasesAntioxidantsApyraseCaffeic AcidsCinnamatesDepsidesEnzyme InhibitorsGallic AcidGlucosidesProtozoan ProteinsQuercetinquercetin 3-O-glucopyranosideQuinic AcidRNA triphosphataseRosmarinic AcidSmall Molecule LibrariesTrypanocidal Agents

Identifiers

PMID26908574
PMCPMC4791841
OpenAlexW2277450365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.